Modified fibrinolytic enzymes

Details Modified fibrinolytic enzymes Modified fibrinolytic enzymes

C - Chemistry, Metallurgy

12

N

167/46, 195/1.22

C12N 15/58 (2006.01) A61K 38/49 (2006.01) A61K 49/00 (2006.01) A61K 51/08 (2006.01) A61P 7/02 (2006.01) C12N 9/72 (2006.01) C12P 21/02 (2006.01)

Patent

CA 1341459

A fibrinolytically active plasminogen activator of the tissue type, wherein the growth factor (G) domain has been deleted, and wherein also the K1 domain has been deleted and additionally has been modified in one or more of the following sites or region: the sites of amino acid residues 177, 184, 277 and 448 and the F domain, the F domain modification if present being a deletion of part or all of said domain; DNA-sequence comprising a nucleotide sequence coding for said plasminogen activator; expression vector which in a transformed host cell can express said DNA-sequence; host cell transformed using such vector; pharmaceutical composition comprising the fibrinolytically active plasminogen activator; plasminogen activator for use in treating thrombotic disease; a process for the manufacture of such fibrinolytically active plasminogen activator; a process for the treatment of thrombotic disorder; and a process of localizing thrombi while using such plasminogen activator.

569728

Affiliated with

Also associated with

Rating

Modified fibrinolytic enzymes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified fibrinolytic enzymes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified fibrinolytic enzymes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1209590